Q-BIO gene Company Profile

10:58 EDT 23rd March 2018 | BioPortfolio

Our roots go back more than 40 years to when Milan Panic founded ICN Pharmaceuticals in 1959 from the basement of his Pasadena home. Mr. Panic used his strategic vision to expand from California into Russia and China, placing ICN in a position to take advantage of the emerging world economy in the new millennium.In 2002, Mr. Panic stepped down as chairman and chief executive officer of ICN Pharmaceuticals and purchased MP Biomedicals. This experience, coupled with his acquisition of MP Biomedicals makes possible a new age of discovery in the life science and biotechnology industries.Today, the company manufactures and sells more than 55,000 products and is one of the only companies in the industry to offer a comprehensive line of life science, fine chemical and diagnostic products.MP Biomedicals is a world-wide corporation, with its headquarters located in Irvine, California and satellite offices in Europe, Asia and Australia. We also maintain a vast network of global distributors, including our ISO 9002 diagnostic products facility in Orangeburg, New York, and distribution centers in Aurora, Ohio and Burlingame, California.No matter how dynamic the evolution of the life science and biotechnology markets, we remain committed to supporting our customers in their efforts to make new discoveries. From basic research, through scale-up, to full-scale production and diagnostic testing, MP Biomedicals serves every industry need – from specialized areas of research to supplying large scale quantities of fine chemicals.


15 Morgan
United States of America


Phone: (800) 854-0530
Fax: 800-334-6999

News Articles [1250 Associated News Articles listed on BioPortfolio]

Direct evidence of the GC-NSF(a) hypothesis on creation of an entirely new gene/protein

(Bentham Science Publishers) The hypothesis assumes that an entirely new gene is produced from the non-stop frame on the antisense strand of a GC-rich gene after gene duplication, followed by the accu...

Gene By Gene Selects BC Platforms to Enhance its World Leading Genomic Data Processing Services

Through its division, Family Tree DNA, Gene by Gene was the first company globally to develop DNA testing for ancestry and genealogical purposes as a Read more...

You’ve Heard All About CRISPR Gene Editing—Here’s How It Works

Gene editing is in the news a lot these days, but what is it exactly? Gene editing is the process of making precise and permanent changes to living things at the level of DNA, or more specifically, to...

Low-cost way to build gene sequences

A new method enables an average biochemistry laboratory to make its own gene sequences for only about $2 per gene, a process that previously would require its researchers to pay a commercial vendor $5...

Gene Therapy 2.0: New Startups Aim to Fine-Tune Gene Delivery and Control

This past month brought a major milestone for gene therapy, a cutting edge type of medicine meant to permanently alter a patient’s genes to treat disease. For the first time, a gene therapy is avail...

#news #biotech DIY DNA sequencing for $2 a gene

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: DIY DNA sequencing for $2 a gene .UCLA scientists were frustrated by the pros...

Scientists using gene editing to stop HIV from infecting cells

Numerous studies are underway to determine how gene therapy and the use of gene-editing tools can possibly cure HIV by using  -More- 

Nanotech, gene editing used to edit cholesterol gene: U.S. study

CHICAGO (Reuters) - U.S. researchers have used nanotechnology plus the powerful CRISPR-Cas9 gene editing tool to turn off a key cholesterol-related gene in mouse liver cells, an advance that could lea...

Drugs and Medications [3 Associated Drugs and Medications listed on BioPortfolio]

R-gene [Pharmacia and Upjohn Company]

R-Gene 10Arginine Hydrochloride Injection, USP

Retin-a micro [Ortho-McNeil Pharmaceuticals]

RETIN-A MICRO® (tretinoin gel) microsphere, 0.1% and 0.04%

Retin-a micro [Physicians Total Care, Inc.]

RETIN-A MICRO® (tretinoin gel) microsphere, 0.1% and 0.04%

PubMed Articles [1724 Associated PubMed Articles listed on BioPortfolio]

Is CAR-T Really Putting Us On Road to Gene Therapy?

CAR-T therapy involves some genetic engineering that is amazing; the culmination of work that began decades ago. But CAR T-cell therapy is not the classic form of gene therapy. Some refer to it as gen...

Study on relationship between Set gene expression and clinical manifestations in bone marrow of patients with acute myelogenous leukemia.

To explore the expression and significance of Set gene in Acute myeloid leukemia (AML) patients , and to analyze its effect for the prognosis of AML.The level of Set gene expression was detected by re...

GNC-app: A new Cytoscape app to rate gene networks biological coherence using gene-gene indirect relationships.

Gene networks are currently considered a powerful tool to model biological processes in the Bioinformatics field. A number of approaches to infer gene networks and various software tools to handle the...

Corrigendum to "Molecular adaptive convergence in the α-globin gene in subterranean octodontid rodents" Gene, 628 (2017) 275-280.

Global inhibition of transcription causes an increase in histone H2A.Z incorporation within gene bodies.

H2A.Z histone variant is an important regulator of gene transcription, which is enriched at regulatory regions but is also found within gene bodies. Recent evidence suggests that active recruitment of...

Clinical Trials [1701 Associated Clinical Trials listed on BioPortfolio]

Genomic Structural Variation in Cancer Susceptibility

This study will look for new types of gene changes that may be related to cancer in some patients. Some gene changes (mutations) are passed on from parents to offspring (child). Other gene...

Gene Therapy in Treating Patients With Cancer of The Liver

RATIONALE: Inserting the p53 gene into a person's tumor may improve the body's ability to fight liver cancer. PURPOSE: Phase I trial to study the effectiveness of gene therapy with the p5...

Phase I Study of Ex Vivo Liver-Directed Gene Therapy for Familial Hypercholesterolemia

OBJECTIVES: I. Develop an approach for treating patients with homozygous familial hypercholesterolemia using gene therapy with autologous hepatocytes transduced with a normal low-density...

Gene Therapy of Beta Thalathemia Using a Self-inactivating Lentiviral Vector

This is a Phase I/II clinical trial of gene transfer for treating Beta-thalassemia using a self-inactivating lentiviral vector to functionally correct the defective gene(s). The objectives...

A Novel Mutation of the Spectrin Gene

The purpose of this study is to find a gene or its mutation (an altered gene) that puts individuals at risk for developing HE or HPP.

Companies [513 Associated Companies listed on BioPortfolio]

Gene Therapy Systems (GTS)

Gene Therapy Systems, Inc. (GTS) designs, develops and commercializes gene therapy products along with other molecular biological reagents for scientists specializing in gene therapy research. GTS is ...


PhenomicDB is a multi-organism phenotype-genotype database including human, mouse, fruit fly, C.elegans, and other model organisms. The inclusion of gene indeces (NCBI Gene) and orthologues (same gene...

Gene Smart

Gene Smart Wellness is a preventative healthcare company dedicated to pioneering real world approaches that empower individuals to take control of their whole health in order to live abundantly. The c...

Sequitur Incorporated

Sequitur, Inc. was founded in 1996 to develop innovative sequence-based compounds for functional genomics research, diagnostic and therapeutic applications. Sequitur's proprietary antisense technolo...

RheoGene Inc

RheoGene is developing the RheoSwitch® Therapeutic System (RTS) for cell and gene therapy. RTS delivers therapeutic gene products in the patient to the right place, at the right time, and at the righ...

More Information about "Q-BIO gene" on BioPortfolio

We have published hundreds of Q-BIO gene news stories on BioPortfolio along with dozens of Q-BIO gene Clinical Trials and PubMed Articles about Q-BIO gene for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Q-BIO gene Companies in our database. You can also find out about relevant Q-BIO gene Drugs and Medications on this site too.

Quick Search


Relevant Topics

Anxiety Disorders
Anxiety is caused by stress. It is a natural reaction, and is beneficial in helping us deal with tense situations and pressure. It is deterimental when is becomes an excessive, irrational dread of everyday situations. The most common types of anxiety di...

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Corporate Database Quicklinks

Searches Linking to this Company Record